Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to identify and describe patient behaviors and clinical outcomes among patients who have tested positive for mild to moderate COVID-19.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Everly Health
NCT05142553 · COVID-19, SARS-CoV-2 Acute Respiratory Disease
NCT05004181 · SARS-CoV-2 Infection, COVID-19, and more
NCT04896866 · Covid19, COVID-19 Pneumonia, and more
NCT05077969 · 2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, and more
NCT04949230 · Covid19, COVID-19 Pneumonia, and more
Everlywell, Inc
Austin, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions